Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
The DNA Replication Fork01:02

The DNA Replication Fork

37.0K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
37.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.8K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

5.9K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRE11 proximal polyadenylation site-mediated looping impacts transcription and genomic stability.

Molecular cell·2026
Same author

RAD51 is chromatin enriched and targetable in BRCA1-deficient cells.

Molecular cell·2025
Same author

Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability.

Nature cancer·2025
Same author

Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer.

DNA repair·2024
Same author

Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction.

Bioorganic & medicinal chemistry·2024
Same author

FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells.

Nature communications·2024
Same journal

ChAHP silences SINE retrotransposons by inhibiting TFIIIB recruitment.

Molecular cell·2026
Same journal

Remodeling activity of ChAHP restricts transcription factor access to chromatin.

Molecular cell·2026
Same journal

Cryo-EM structure of soluble VPS13C suggests its regulation by a conformational switch and by calmodulin.

Molecular cell·2026
Same journal

HDAC5 depletion promotes hyper-acetylation of FOXA1 and potentiates HIF1α transcriptional activation in pancreatic cancer.

Molecular cell·2026
Same journal

Thyroid cancer-associated EZH1 Q571R mutation drives chromatin compaction and H3K27me3 invasion into active chromatin.

Molecular cell·2026
Same journal

Genome-wide rotational and translational phasing of nucleosomes with human transcription factors.

Molecular cell·2026
See all related articles

Related Experiment Video

Updated: Sep 23, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

506

Exploiting replication gaps for cancer therapy.

Ke Cong1, Sharon B Cantor1

  • 1Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.

Molecular Cell
|May 14, 2022
PubMed
Summary
This summary is machine-generated.

BRCA mutations, often linked to DNA repair defects, may sensitize tumors to PARP inhibitors (PARPis) by impacting lagging strand DNA synthesis. This suggests BRCAness and PARPi vulnerability stem from shared roles in DNA replication, leading to toxic gaps.

Keywords:
BRCA cancerPARP inhibitorcancer therapychemoresistancesingle-stranded DNAsynthetic lethality

More Related Videos

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay
10:32

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay

Published on: February 3, 2022

6.7K
G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome
06:40

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome

Published on: March 22, 2018

5.9K

Related Experiment Videos

Last Updated: Sep 23, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

506
Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay
10:32

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay

Published on: February 3, 2022

6.7K
G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome
06:40

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome

Published on: March 22, 2018

5.9K

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • BRCA1/BRCA2 (BRCA) mutations are traditionally associated with defects in DNA double-strand break repair.
  • Tumors with BRCA mutations are often considered selectively sensitive to poly(ADP-ribose) polymerase inhibitors (PARPis).

Purpose of the Study:

  • To challenge the established framework linking BRCAness solely to double-strand break repair defects.
  • To explore the shared functions of BRCA proteins and PARP1 in DNA synthesis, specifically on the lagging strand.
  • To propose an alternative model for PARPi sensitivity in BRCA-deficient or BRCAness tumors.

Main Methods:

  • Investigated the functional overlap between BRCA proteins and PARP1 in DNA replication.
  • Analyzed the consequences of BRCA deficiency on lagging strand DNA synthesis.
  • Examined the impact of PARPi on cells with BRCA deficiency or "BRCAness".

Main Results:

  • BRCA proteins and PARP1 share critical functions in DNA synthesis on the lagging strand.
  • BRCA deficiency or "BRCAness" may represent an inherent lagging strand synthesis problem.
  • Co-targeting the lagging strand with PARPi in BRCA-deficient contexts leads to a toxic accumulation of replication gaps.

Conclusions:

  • BRCAness-associated PARPi sensitivity may arise from targeting shared lagging strand DNA synthesis functions.
  • This revised understanding offers a new perspective on the mechanism of action for PARPis in BRCA-mutant and BRCAness tumors.
  • The combination of BRCA deficiency and PARPi treatment creates a synthetic lethal interaction through replication stress.